The stem cell therapy market would grow at a CAGR of 13.73% over the predicted time frame. The market is expected to increase in value from US$ 11.22 Bn in 2022 to US$ 31.41 Bn in 2030.
The on stem cell therapy Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/1989
Report Scope of the Stem Cell Therapy Market
Report Coverage | Details |
Market Size in 2022 | USD 11.22 Billion |
Market Size by 2030 | USD 31.41 Billion |
Growth Rate from 2022 to 2030 | CAGR of 13.73% |
Base Year | 2021 |
Forecast Period | 2022 to 2030 |
Segments Covered | Product, Therapy Type, Application, Technology, End User, Geography |
A recent report provides crucial insights along with application based and forecast information in the Global Stem cell therapy Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Stem cell therapy market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Stem cell therapy market are included as given below:
Stem cell therapy Market Key Players
- Caladrius
- CELGENE CORPORATION
- ReNeuron Group plc
- Virgin Health Bank
- Opexa Therapeutics, Inc.
- Pluristem Therapeutics Inc
- STEMCELL Technologies Inc.
- Biovault family
- Precious Cells International Ltd
- Mesoblast Ltd
- Seneca Biopharmaceuticals, Inc.
Market Segments
By Product
- Adult Stem Cells (ASCs)
- Hematopoietic
- Mesenchymal
- Neural
- Epithelial/Skin
- Others
- Human Embryonic Stem Cells (HESCs)
- Induced Pluripotent Stem Cells (iPSCs)
- Very Small Embryonic Like Stem Cells
By Therapy Type
- Autologous
- Allergenic
By Application
- Regenerative Medicine
- Neurology
- Orthopedics
- Oncology
- Hematology
- Cardiovascular and Myocardial Infraction
- Injuries
- Diabetes
- Liver Disorder
- Incontinence
- Others
- Drug Discovery and Development
By Technology
- Cell Acquiition
- Bone Marrow Harvest
- Umbilical Blood Cord
- Apheresis
- Cell Production
- Therapeutic Cloning
- In-vitro Fertilization
- Cell Culture
- Isolation
- Cryopreservation
- Expansion and Sub-Culture
By End User
- Hospitals
- Research institutes
- surgical institutes
- Orders
By Geography
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Philippines
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC
- North Africa
- South Africa
- Rest of the Middle East & Africa
Report Objectives
- To define, describe, and forecast the global stem cell therapy market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the stem cell therapy market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Stem Cell Therapy Market
5.1. COVID-19 Landscape: Stem Cell Therapy Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Stem Cell Therapy Market, By Product
8.1. Stem Cell Therapy Market, by Product, 2022-2030
8.1.1. Adult Stem Cells (ASCs)
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Human Embryonic Stem Cells (HESCs)
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Induced Pluripotent Stem Cells (iPSCs)
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Very Small Embryonic Like Stem Cells
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Stem Cell Therapy Market, By Therapy Type
9.1. Stem Cell Therapy Market, by Therapy Type, 2022-2030
9.1.1. Autologous
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Allergenic
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Stem Cell Therapy Market, By Application
10.1. Stem Cell Therapy Market, by Application, 2022-2030
10.1.1. Regenerative Medicine
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Drug Discovery and Development
10.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Stem Cell Therapy Market, By Technology
11.1. Stem Cell Therapy Market, by Technology, 2022-2030
11.1.1. Cell Acquiition
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Cell Production
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Cryopreservation
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Expansion and Sub-Culture
11.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Stem Cell Therapy Market, By End User
12.1. Stem Cell Therapy Market, by End User, 2022-2030
12.1.1. Hospitals
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Research institutes
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. surgical institutes
12.1.3.1. Market Revenue and Forecast (2017-2030)
12.1.4. Orders
12.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Stem Cell Therapy Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.1.3. Market Revenue and Forecast, by Application (2017-2030)
13.1.4. Market Revenue and Forecast, by Technology (2017-2030)
13.1.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.1.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.1.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.1.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.1.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.1.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.1.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.7. Germany
13.2.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.8. France
13.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.8.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.8.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.8.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.2.9. Rest of Europe
13.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.2.9.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.2.9.3. Market Revenue and Forecast, by Application (2017-2030)
13.2.9.4. Market Revenue and Forecast, by Technology (2017-2030)
13.2.9.5. Market Revenue and Forecast, by End User (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.7. China
13.3.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.8. Japan
13.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.8.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.8.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.8.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.3.9. Rest of APAC
13.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.3.9.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.3.9.3. Market Revenue and Forecast, by Application (2017-2030)
13.3.9.4. Market Revenue and Forecast, by Technology (2017-2030)
13.3.9.5. Market Revenue and Forecast, by End User (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.7. North Africa
13.4.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.7.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.8. South Africa
13.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.8.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.8.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.8.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.8.5. Market Revenue and Forecast, by End User (2017-2030)
13.4.9. Rest of MEA
13.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
13.4.9.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.4.9.3. Market Revenue and Forecast, by Application (2017-2030)
13.4.9.4. Market Revenue and Forecast, by Technology (2017-2030)
13.4.9.5. Market Revenue and Forecast, by End User (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.5.3. Market Revenue and Forecast, by Application (2017-2030)
13.5.4. Market Revenue and Forecast, by Technology (2017-2030)
13.5.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.6.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.5.6.3. Market Revenue and Forecast, by Application (2017-2030)
13.5.6.4. Market Revenue and Forecast, by Technology (2017-2030)
13.5.6.5. Market Revenue and Forecast, by End User (2017-2030)
13.5.7. Rest of LATAM
13.5.7.1. Market Revenue and Forecast, by Product (2017-2030)
13.5.7.2. Market Revenue and Forecast, by Therapy Type (2017-2030)
13.5.7.3. Market Revenue and Forecast, by Application (2017-2030)
13.5.7.4. Market Revenue and Forecast, by Technology (2017-2030)
13.5.7.5. Market Revenue and Forecast, by End User (2017-2030)
Chapter 14. Company Profiles
14.1. Caladrius
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. CELGENE CORPORATION
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. ReNeuron Group plc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Virgin Health Bank
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Opexa Therapeutics, Inc
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Pluristem Therapeutics Inc
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. STEMCELL Technologies Inc.
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Biovault family
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Precious Cells International Ltd
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Mesoblast Ltd
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments